Name | Number of supported studies | Average coverage | |
---|---|---|---|
microglial cell | 7 studies | 24% ± 8% | |
epithelial cell | 5 studies | 28% ± 11% | |
macrophage | 5 studies | 24% ± 8% | |
ciliated cell | 3 studies | 21% ± 4% | |
GABAergic neuron | 3 studies | 33% ± 3% | |
glutamatergic neuron | 3 studies | 41% ± 3% | |
oligodendrocyte precursor cell | 3 studies | 25% ± 8% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 31% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 1433.63 | 459 / 459 | 100% | 21.99 | 1118 / 1118 |
pancreas | 100% | 1535.30 | 328 / 328 | 100% | 12.07 | 178 / 178 |
prostate | 100% | 2283.24 | 245 / 245 | 100% | 39.26 | 502 / 502 |
stomach | 100% | 1649.06 | 359 / 359 | 100% | 14.90 | 286 / 286 |
esophagus | 100% | 1731.54 | 1444 / 1445 | 100% | 17.44 | 183 / 183 |
intestine | 100% | 1319.25 | 966 / 966 | 100% | 16.22 | 526 / 527 |
bladder | 100% | 1480.67 | 21 / 21 | 100% | 15.37 | 503 / 504 |
uterus | 100% | 1511.89 | 170 / 170 | 100% | 15.55 | 458 / 459 |
kidney | 100% | 1245.03 | 89 / 89 | 99% | 15.87 | 895 / 901 |
lung | 99% | 1270.16 | 574 / 578 | 100% | 15.60 | 1155 / 1155 |
thymus | 100% | 1200.34 | 652 / 653 | 99% | 10.69 | 598 / 605 |
ovary | 100% | 1373.84 | 180 / 180 | 98% | 8.80 | 421 / 430 |
brain | 98% | 990.60 | 2585 / 2642 | 100% | 16.52 | 705 / 705 |
skin | 100% | 2941.41 | 1809 / 1809 | 97% | 15.74 | 458 / 472 |
adrenal gland | 99% | 1198.17 | 256 / 258 | 96% | 11.24 | 221 / 230 |
liver | 100% | 847.41 | 226 / 226 | 86% | 6.01 | 350 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 28.15 | 29 / 29 |
muscle | 100% | 7536.31 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2368.41 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 15.08 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.13 | 1 / 1 |
adipose | 100% | 1256.15 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 913.69 | 1321 / 1335 | 0% | 0 | 0 / 0 |
heart | 92% | 967.76 | 792 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 88% | 6.42 | 70 / 80 |
peripheral blood | 79% | 1588.70 | 732 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0034198 | Biological process | cellular response to amino acid starvation |
GO_0031669 | Biological process | cellular response to nutrient levels |
GO_0032289 | Biological process | central nervous system myelin formation |
GO_1904263 | Biological process | positive regulation of TORC1 signaling |
GO_0048709 | Biological process | oligodendrocyte differentiation |
GO_0070444 | Biological process | oligodendrocyte progenitor proliferation |
GO_1904262 | Biological process | negative regulation of TORC1 signaling |
GO_0031503 | Biological process | protein-containing complex localization |
GO_0030054 | Cellular component | cell junction |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0061700 | Cellular component | GATOR2 complex |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | MIOS |
Protein name | Meiosis regulator for oocyte development GATOR2 complex protein MIOS (Missing oocyte meiosis regulator homolog) |
Synonyms | |
Description | FUNCTION: As a component of the GATOR2 complex, functions as an activator of the amino acid-sensing branch of the mTORC1 signaling pathway . The GATOR2 complex indirectly activates mTORC1 through the inhibition of the GATOR1 subcomplex . GATOR2 probably acts as an E3 ubiquitin-protein ligase toward GATOR1 . In the presence of abundant amino acids, the GATOR2 complex mediates ubiquitination of the NPRL2 core component of the GATOR1 complex, leading to GATOR1 inactivation . In the absence of amino acids, GATOR2 is inhibited, activating the GATOR1 complex . Within the GATOR2 complex, MIOS is required to prevent autoubiquitination of WDR24, the catalytic subunit of the complex . The GATOR2 complex is required for brain myelination (By similarity). . |
Accessions | ENST00000405785.5 [Q9NXC5-1] ENST00000340080.9 [Q9NXC5-1] ENST00000433635.1 Q9NXC5 C9JUE6 C9JAQ1 ENST00000445169.1 ENST00000433056.5 C9JTV2 ENST00000456533.1 |